Answers are grounded in this paper and cite their sources.
Objective: The aim of this study was to assess how short-term personal CGM with professional support would affect treatment decisions and glucose control in people with type 1 (T1D) and 2 (T2D) diabetes treated with insulin in clinical practice. Materials and methods: This was a single-center retrospective cohort study of insulin-treated patients with diabetes who attended the diabetes clinic between March 2021 and March 2022 in Ruttonjee Hospital. It included 90 people with diabetes who were offered a physician-initiated 10 to 14-day CGM (rtCGM or isCGM) in addition to usual care (CGM group), and 90 people with diabetes with usual care alone (control group) after propensity score matching. Upon completion of CGM, the downloaded report was read by physicians for treatment advice (CGM group). Results: The overall mean HbA1c decreased in the CGM group compared with the control group (adjusted group difference, –0.40%; 95% CI, –0.68 to –0.12%; p = 0.005). In T2D, mean HbA1c decreased in the CGM group compared with the control (adjusted group difference, –0.46%; 95% CI, –0.78% to –0.15%; p = 0.005). The mean HbA1c decrease was non-significant in T1D between CGM and control groups. CGM intervention resulted in 69% in the CGM group had an additional pharmacological adjustment, 60% had dietary advice, and 13.3% had corrected matching of insulin doses to carbohydrates. Conclusions: This study demonstrated that a 10 to 14-day CGM with professional support is beneficial in improving glucose control for people with diabetes treated with insulin in the outpatient clinic.
No takes yet. Share an insight, caveat, or question.
Tin-Wai Wong (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: